Concentration of soluble form of hepatocyte growth factor receptor in cerebrospinal fluid and serum of patients with bacterial and viral meningitis

Khoshdel Rad N,; Mashayekhi F,; Mirzajani E,

Volume 6, Issue 1 (spring-summer[PERSIAN] 2012) mljgoums 2012, 6(1): 1-6 | Back to browse issues page

Mendeley

Zotero

RefWorks

Khoshdel Rad N, Mashayekhi F, Mirzajani E. Concentration of soluble form of hepatocyte growth factor receptor in cerebrospinal fluid and serum of patients with bacterial and viral meningitis. mljgoums 2012; 6 (1) :1-6
URL: http://mlj.goums.ac.ir/article-1-193-en.html

Concentration of soluble form of hepatocyte growth factor receptor in cerebrospinal fluid and serum of patients with bacterial and viral meningitis

Khoshdel Rad N¹

, Mashayekhi F

², Mirzajani E³

1- Master student, Department of Biology,
2- Associate Professor Department of Biology, , mashayekhi@guilan.ac.ir
3- Assistant Professor of Cellular and Molecular Research Center

Abstract: (18939 Views)

Abstract Background and objectives: C-Met is a proto-oncogene that encodes a protein known as hepatocyte growth factor receptor (HGFR). The HGF receptor possesses tyrosine -kinase activity and it is essential for embryonic development, wound healing and cancer. Many proteins are proteolytically released from the surface by a process known as ectodomain shedding. Shedding occurs under normal physiologic conditions and can be increased in certain pathologies. C-Met can be seen among many receptors for which ectodomain shedding has been shown. The aim of this study was to determine the concentration of soluble c-Met in the cerebrospinal fluid (CSF) and serum samples of patients with viral and bacterial meningitis. Material and Methods: in this study, 75 CSF and serum samples of patients with bacterial meningitis, 71 with viral meningitis and 82 normal controls were investigated. The soluble c-Met concentration was determined by enzyme linked immunosorbent assay (ELISA). Result: the amount of soluble c-met in CSF of patients with bacterial meningitis ( 83.91±5.50), viral meningitis ( 80.41±4.71) and control group ( 22.66±3.39) are compared with that in serum of patients with bacterial meningitis ( 561.58±25.87), viral meningitis ( 550.50 ±34.34) and control group ( 256.25±18.55). There is significant increase in the CSF and serum’s soluble c-Met expression in the patients with meningitis, in comparison with control group. Conclusion: The data presented here indicate that soluble c-Met is a constant component of human serum and CSF, but it can not be used for differentiating bacterial meningitis from viral meningitis. Key words: Soluble c-Met, concentration, cerebrospinal fluid, serum, meningitis

Keywords: Soluble c-Met, concentration, cerebrospinal fluid, serum, meningitis

Full-Text [PDF 187 kb] [English Abstract] (3754 Downloads)

Research Article: Original Paper |
Received: 2012/08/1 | Accepted: 2014/01/12 | Published: 2014/01/12 | ePublished: 2014/01/12